Massachusetts Set to Allow Out-of-State Patients Access to Medical Cannabis
Massachusetts may soon allow patients from other U.S. states to purchase medical marijuana in its clinics. A proposal currently under review by the Cannabis Control Commission (CCC) would eliminate residency restrictions, which could expand access for patients while offering new opportunities to a medical cannabis market facing declining sales.
Massachusetts is considering eliminating residency requirements for medical cannabis
Presented at a meeting on October 22, the proposed regulations would allow the non-resident patients aged 18 and older to register for the Massachusetts Medical Cannabis Program, provided they have been diagnosed with an eligible disabling medical condition by a healthcare professional licensed in the state.
Patients under the age of 18 would be subject to stricter requirements. In addition, their condition would have to be considered a life-limiting illness, as certified by two healthcare professionals.
This initiative aims to make it easier for patients traveling to Massachusetts to access treatment, whether for medical appointments, family visits, or any other reason.
«Simply put, it’s a highly effective and well-thought-out way to make it easier for patients across the country to access treatment, regardless of why they use medical cannabis,» said the commissioner Xiomara DeLobato to the State House News Service.
If approved, Massachusetts will join its neighboring states, including the New Hampshire, the Rhode Island, the Connecticut, New York and the Maine, which already offer nonresidents access to medical cannabis.
A Potential Lifeline for Massachusetts' Struggling Medical Cannabis Market
Beyond improving patient access, this proposal could provide financial relief to the’medical cannabis industry in Massachusetts, which is experiencing a prolonged slowdown.
According to CCC figures cited by the State House News Service, medical cannabis sales in September rose from $17.9 million in 2023 to $11.2 million in 2026, representing a decline of approximately 37 %.
Jeremiah MacKinnon, president and executive director of the Massachusetts Patient Advocacy Alliance, called the proposed changes «a step in the right direction toward modernizing our medical program.».
He also emphasized the importance of ensuring continuity of care for patients traveling to Massachusetts, particularly given the state’s extensive healthcare infrastructure.
Unlike recreational products, Purchases of medical cannabis are exempt from state cannabis taxes. Products intended for adults—available to anyone 21 years of age or older, regardless of place of residence—are subject to a sales tax of 6.25 %, an excise tax of 10.75 %, and, in some cases, an additional municipal tax of 3 %.
Expanding the eligibility criteria for medical cannabis could therefore make the regulated medical system more attractive to eligible patients, while supporting dispensaries facing a decline in demand.
A Regulatory Debate Amid Uncertainty Surrounding Recreational Cannabis
This proposal also comes at a politically sensitive time for the legalization of cannabis in Massachusetts.
The Voters will decide on Question 8 in November, a citizens' initiative aimed at repealing the state's recreational cannabis market.
Ryan Dominguez, executive director of the Massachusetts Cannabis Coalition, suggested that expanded medical access could take on particular importance if voters approved this repeal.
The proposed rules, however, remain separate from the referendum and would not automatically result in the recognition of medical cannabis authorizations issued by other states.
A similar reciprocity provision had previously been passed by the Massachusetts Senate, but it was removed during negotiations with the House of Representatives before the governor Maura Healey will not sign broader cannabis legislation in April 2026.
A final decision is expected following a public consultation
The Cannabis Control Commission plans to hold an initial vote on December 10, 2026, followed by a public consultation scheduled for January 1 through February 2, 2027. The regulatory authorities could then amend the proposal before proceeding to the final vote.
For Massachusetts, this debate reflects a broader challenge facing established legal cannabis markets: striking a balance between patient access, regulatory oversight, and the economic viability of medical dispensaries, alongside recreational retail sales.
-
Business3 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France4 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec2 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in the U.S.4 weeks ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Cannabis in France4 weeks ago
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
-
Business4 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
Cannabis in New Zealand2 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep
-
CBD4 weeks ago
October 2026 CBD Highlights: 10 Strains and Hash to Discover from 5 French Producers


You must be logged in to post a comment Login